Pages

Wednesday, November 17, 2021

Pfizer Moves to Get US Authorization for Antiviral Covid Pill

Pfizer announced on Tuesday that it has filed for U.S. authorization of the company’s new antiviral Covid-19 pill. The pill, called Paxlovid, has yielded impressive results in clinical trials, reducing hospitalization or death by 89%. If approved, the drug could prove to be a gamechanger for those most vulnerable to severe illness, as well as […] Read the full story on GreekReporter.com.


READ THE ORIGINAL POST AT greekreporter.com